MRKR
MRKR
NASDAQ · Biotechnology

Marker Therapeutics Inc

$1.13
-0.03 (-2.17%)
As of Sep 28, 10:34 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.86M
Net Income
-13,246,798
Gross Margin
—
Profit Margin
-343.0%
Rev Growth
-26.7%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.86M 5.27M 3.86M 4.10M
Gross Profit — — 2.51M 2.67M
Operating Income -14,040,665 -17,241,913 -161,214 -174,270
Net Income -13,246,798 -16,267,046 -155,305 -171,738
Gross Margin — — 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Rev Growth -26.7% -26.7% +19.6% -4.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.32M 9.35M
Total Equity — — 11.45M 10.87M
D/E Ratio — — 0.81 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,037,104 -18,195,181 -205,551 -243,961
Free Cash Flow — — -168,121 -167,490